Full Text
The Cost-Effectiveness of Ustekinumab in Moderate to Severely Active Crohn’s Disease in Sweden

Abstract

Authors

A Hansson-Hedblom C Almond F Borgström I Sly D Enkusson A Troelsgaard Buchholt L Karlsson

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×